Claude Science is Anthropic's AI workbench for computational research — not a content tool. Honest comparison vs Kompozy: when the workbench fits, and when you need to publish.
If you searched "Claude Science vs Kompozy" or "Claude Science alternative," the most useful thing I can tell you up front is that these are not the same kind of product. Claude Science is a research workbench for scientists. Kompozy is a content generation and publishing engine. They sit on opposite sides of a single boundary — the moment a finding stops being lab work and starts being something you want an audience to see.
I run Kompozy, so read this as positioned. But I am not going to pretend Claude Science is a content rival we out-feature. It is a genuinely strong tool for the job it was built for. Anthropic launched it in beta on June 30, 2026 as one environment for computational research: a coordinating Claude agent with 60+ curated databases and prebuilt skills for genomics, proteomics, structural biology, and cheminformatics; custom expert sub-agents; a reviewer agent that checks citations and calculations; native rendering of proteins, molecules, and genomic tracks; and reproducible outputs from raw data to figure. If your problem is "I need to run and document research," Claude Science is a real answer and Kompozy is not what you want.
The reason a creator or a science-brand marketer lands on this page is usually that they have research worth talking about and assumed a tool named "Claude Science" might also help them talk about it publicly. It does not. Claude Science produces figures, analyses, and manuscript drafts — it generates no video, no carousels, no captions, no finished posts, and it publishes nothing. It is the lab, not the broadcast.
Everything below reconciles Claude Science against Anthropic's own launch announcement and Kompozy pricing against ours, both checked on 2026-06-30.
Claude Science is an AI workbench for scientists from Anthropic, in beta on macOS and Linux for Pro, Max, Team, and Enterprise plans. A generalist coordinating agent plans the work with access to 60+ scientific databases and prebuilt skills, can spin up sub-agents or hand tasks to custom expert agents, and a separate reviewer agent checks citations and calculations before results reach a manuscript. The app renders scientific artifacts natively — protein structures, molecules, alignments, genomic tracks, PDFs — manages compute from laptops to HPC clusters via persistent Python and R kernels, and preserves full lineage from data to publication-ready figure. Notably, it is not a new model; it runs existing Claude models, including Opus 4.8. What it does, concretely, is research: analyze data, manage computation, keep figures reproducible, and draft manuscripts with checked citations. What it does not do is anything downstream of the science. There is no image, video, or audio generation for an audience; no captioning, design templates, or carousels; no scheduler; no social or email publishing; and no brand-voice layer that carries a finding into a public post. It is a workbench you do research in, not a tool that distributes the results.
The reason "just use Claude Science" does not hold up for a communications workflow is that a reviewed finding is several layers away from a published explainer. To get from a Claude Science figure to a LinkedIn carousel or a YouTube short you would still need video and image generation the workbench does not do, plus captioning, branded design, scheduling, and platform integrations — and a voice layer to keep it all sounding like your lab or brand rather than a methods section. That is an entire production stack the workbench sits beside, not inside. None of this is a knock on Claude Science. It set out to consolidate computational research into one reproducible environment, and by the early accounts it does that well. It simply lives on the research side of the line, while audience content lives on the other. If you want to run rigorous analysis, use Claude Science. If you want to turn what you found into finished, on-brand content across platforms, you want a content engine — and the sensible pairing is to run both: the science in Claude Science, the communication in Kompozy.
| Feature | Claude Science | Kompozy | Note |
|---|---|---|---|
| Computational research / analysis | Yes | No | Claude Science's entire purpose and it is strong at it. Kompozy is not a research or data-analysis tool. |
| Reproducible figures from raw data | Yes | No | Claude Science preserves full data-to-figure lineage. Kompozy consumes a finished figure, it does not produce one from data. |
| Citation / calculation fact-checking | Yes | Partial | Claude Science runs a dedicated reviewer agent for scientific accuracy. Kompozy governs copy via a Persona Brief and banned-word filters, not scientific verification. |
| On-brand copywriting across formats | No | Yes | Claude Science drafts manuscripts, not branded marketing copy. Kompozy enforces voice via the Persona Brief across every format. |
| AI image generation (carousels, posters, cards) | No | Yes | No audience media from Claude Science. Kompozy renders photo posts, carousels, quote cards, infographics. |
| AI / avatar video generation | No | Yes | Claude Science renders scientific artifacts, not presenter video. Kompozy ships persona/avatar video, clips, marketing shorts. |
| Branded design templates (HyperFrames) | No | Yes | No marketing design layer in a research workbench. Kompozy renders pixel-exact brand styling. |
| Scheduling + autopilot | No | Yes | Claude Science has no publishing calendar. Kompozy ships a scheduler, autopilot, and review pipeline. |
| Multi-platform publishing (9 platforms + email + blog) | No | Yes | Claude Science publishes nothing to an audience. Kompozy fans output to all destinations from one queue. |
| One source → many outputs fan-out | No | Yes | Kompozy fans one finding into 18 formats across five buckets and ships them. A workbench produces a result, not a content set. |
| Works without a science/coding background for content | Partial | Yes | Claude Science targets researchers; content from it still needs a separate stack. Kompozy is log-in-and-use for the content half. |
| Runs on existing Claude models | Yes | Yes | Claude Science runs Claude (incl. Opus 4.8) for research. Kompozy runs Claude generation for content. |
| Tier | Claude Science plan | Claude Science price | Kompozy plan | Kompozy price |
|---|---|---|---|---|
| Entry | Claude Science (Pro plan) | Included with an eligible Claude plan; no standalone price published | Kompozy Creator | $49/mo (2,500 credits) |
| Mid | Claude Team (incl. academic/nonprofit discount) | Team plan; discounted plan for academic labs and nonprofits | Kompozy Pro | $299/mo (18,000 credits) |
| Top | Claude Enterprise | Enterprise plan (admin-enabled, sales-led) | Kompozy Enterprise | Custom (sales-led) |
Here is the honest pitch, because Claude Science and Kompozy answer different questions. Claude Science is a research workbench — a strong one — for running, checking, and documenting computational science. If your problem is "I need to do and reproduce research," Claude Science is a great call and a Kompozy page is not where your search should end.
But a workbench is not a content operation. Claude Science produces figures, analyses, and manuscript drafts; it generates no audience media, holds no brand voice, and publishes nothing. To get from a reviewed finding to a published Reel, carousel, or newsletter you would bolt on image and video generation, captioning, branded design, a scheduler, and nine platform integrations — and the voice layer to keep it all on-brand. Kompozy is that entire layer, already built and managed, and it runs Claude generation under the hood — so you get Claude-class drafting in your own voice through a Persona Brief, plus the 18 formats, the media rendering, and publishing to nine platforms plus email and blog on autopilot.
The cleanest way to decide: if you care most about doing the research, choose Claude Science. If you care most about communicating it, choose Kompozy — and the strongest setup is to run both: keep the science in Claude Science, then let Kompozy turn every finding into a finished, scheduled explainer set. Start on Kompozy Creator at $49/mo (2,500 credits) to test the content half.
Not really — they sit on opposite sides of one boundary. Claude Science is a research workbench you do science in; Kompozy is a content generation and publishing engine you communicate science with. People compare them because both are AI products, but Claude Science produces figures and manuscripts while Kompozy produces finished, scheduled posts. For a content workflow they barely overlap.
No. It generates research outputs — analyses, figures, manuscript drafts — not audience media, and it publishes nothing. To turn a finding into a video, carousel, blog, or newsletter across platforms you use a content engine like Kompozy.
When your need is the research itself — running analyses, managing compute, keeping figures reproducible, and checking citations. In that case the workbench is exactly right and a content engine is not. The two are complements, not substitutes.
Claude Science is in beta and bundled into Anthropic's Pro, Max, Team, and Enterprise plans (with a discounted Team plan for academic and nonprofit labs); Anthropic did not publish a standalone price. Kompozy is a managed subscription starting at $49/mo (2,500 credits) for Creator and $299/mo (18,000 credits) for Pro, with no research or coding background required.
Yes, and that is the recommended setup. Keep the science in Claude Science, where reproducibility and citation-checking belong. Then bring the headline finding and figure into Kompozy, which runs Claude generation, and let it produce an explainer short, a figure carousel, a blog, and a newsletter and publish them across platforms.